ArticleLeukemia2023
Outstanding outcomes with two low intensity regimens in children with low-risk B-ALL: a report from COG AALL0932.
Erratum issuedAbstract readLetter
In one paragraph
Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.The New England journal of medicine · 2025Trial
- Minimal residual disease by high-throughput sequencing in standard risk-favorable pediatric B-lymphoblastic leukemia.Blood advances · 2026Article
- Real-World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital-Dispensed Model.Pediatric blood & cancer · 2026Article
- Revisiting novel genomic classifiers in the era of immunotherapy for pediatric B-ALL.Hematology. American Society of Hematology. Education Program · 2025Review
- The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy era.Hematology. American Society of Hematology. Education Program · 2025Review
- Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia.Leukemia · 2025Article
- Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- Rethinking paraneoplastic eosinophilia.Haematologica · 2024Article
- Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023Review
- Article
- Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia.Pediatric blood & cancer · 2023Article
Corrections and comments
- Erratum issued
Authors and funding
20 authors.
Reuven J SchoreChildren's National Health System, Washington, DC, USA. rschore@childrensnational.org.ORCID http://orcid.org/0000-0002-1582-2168
Anne L AngiolilloChildren's National Health System, Washington, DC, USA.
John A KairallaDepartment of Biostatistics, Colleges of Medicine, Public Health & Health Professions, University of Florida, Gainesville, FL, USA.
Meenakshi DevidasDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN, USA.
Karen R RabinTexas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0002-4081-8195
Patrick Zweidler-McKayImmunoGen, Inc., Boston, MA, USA.
Michael J BorowitzDepartment of Pathology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
Brent WoodDepartment of Laboratory Medicine, University of Washington, Seattle, WA, USA.
Andrew J CarrollDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID http://orcid.org/0000-0001-9844-730X
Nyla A HeeremaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Mary V RellingSt Jude's Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-3720-9591
Johann HitzlerHospital for Sick Children, Toronto, ON, Canada.ORCID http://orcid.org/0000-0003-1158-186X
Nina S Kadan-LottickGeorgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.ORCID http://orcid.org/0000-0002-6857-396X
Kelly MaloneyChildren's Hospital Colorado and the Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
Cindy WangDepartment of Biostatistics, Colleges of Medicine, Public Health & Health Professions, University of Florida, Gainesville, FL, USA.
William L CarrollDepartment of Pediatrics and Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
Naomi J WinickUniversity of Texas Southwestern Medical Center, Dallas, TX, USA.ORCID http://orcid.org/0000-0002-6636-3870
Elizabeth A RaetzDepartment of Pediatrics and Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
Mignon L LohBen Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, WA, USA.
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, the Children's Hospital of Philadelphia, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-5492-3957
Funding
NCTN BIQSFP ANBL1531 (NRT)U10CA180886 · NCI · PUBLIC HEALTH INSTITUTE · PI Douglas S. Hawkins · 2014 to 2026
$390.6MCOG FOREIGN ACCRUALU10CA098543 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI ADAMSON, PETER C. · 2003 to 2013
$335.5MCOG SDMC - Statistics CoreU10CA180899 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI TODD A ALONZO · 2014 to 2026
$132.8MChildren's Oncology Group Statistics &Data Center GrantU10CA098413 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ANDERSON, JAMES R · 2003 to 2013
$67.5MCOG U24 Funding 2026-2027U24CA196173 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI Mignon Lee-Cheun Loh, Nilsa Del Carmen Ramirez Milan · 2015 to 2026
$62.5MSupport for Human Specimen Banking in NCI-Supported Cancer Clinical TrialsU24CA114766 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI RAMIREZ MILAN, NILSA DEL CARMEN · 2005 to 2014
$14.5MNCI NIH HHS U10 CA098413NCI NIH HHS U10 CA098543NCI NIH HHS U10 CA180886NCI NIH HHS U10 CA180899NCI NIH HHS U24 CA114766NCI NIH HHS U24 CA196173
Abstract
PubMed holds no abstract for this paper.
Indexed as
Precursor B-Cell Lymphoblastic Leukemia-LymphomaChildHumansRisk
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.